Tyk2-IN-28
Tyk2-IN-28 is an orally active and selective TYK2 inhibitor with an IC50 of 0.9 nM. Tyk2-IN-28 also inhibits JAK2 kinase activity with an IC50 of 4 nM. Tyk2-IN-28 blocks inflammatory cytokine signaling. Tyk2-IN-28 reduces paw swelling in mouse models. Tyk2-IN-28 can be used for research on psoriasis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C23H21N9
- Masse moléculaire:423.47
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Description
IC50 & Target
[1]|
JAK1 10 nM (IC50) |
Tyk2 0.9 nM (IC50) |
JAK2 4 nM (IC50) |
JAK3 189 nM (IC50) |
In Vitro
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:IL-23-induced psoriasis[1]
-
Dosage:10, 20, 50 mg/kg
-
Administration:p.o.; twice daily; 6 h interval; for 8 consecutive day
-
Result:Had no significant effect on the body weight of C57BL/6 mice in the model of IL-23-induced abnormal epidermal hyperplasia of the ear.
Inhibited the increase in ear thickness and reduces ear weight.
Chemical Information
-
Masse moléculaire 423.47
-
Formule C23H21N9
-
SMILES
CN1N=CC(C2=CN3N=CC=C3C(C4=CN([C@@]5(CC#N)C[C@]6(C[C@H](C#N)C6)C5)N=C4)=N2)=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Tyk2-IN-28 Related Classifications
HY-187467 Related Classifications
Powered by Bioz